Evaluating the immunogenicity of chemically-synthesised peptides derived from foot-and-mouth disease VP1, VP2 and VP3 proteins as vaccine candidates.
Avendaño C, Celis-Giraldo C, Ordoñez D, Díaz-Arévalo D, Rodríguez-Habibe I, Oviedo J, Curtidor H, García-Castiblanco S, Martínez-Panqueva F, Camargo-Castañeda A, Reyes C, Bohórquez MD, Vanegas M, Cantor D, Patarroyo ME, Patarroyo MA.
Avendaño C, et al. Among authors: bohorquez md.
Vaccine. 2020 May 13;38(23):3942-3951. doi: 10.1016/j.vaccine.2020.04.006. Epub 2020 Apr 16.
Vaccine. 2020.
PMID: 32307277